SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

La Fortune Gordon

(Last)

(First)

(Middle)

C/O CAREFUSION CORPORATION

3750 TORREY VIEW COURT

(Street)

SAN DIEGO

92130

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/03/2010

3. Issuer Name and Ticker or Trading Symbol
CareFusion Corp [ CFN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP and GM, Infusion

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6,344	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)⁽¹⁾	⁽²⁾	07/20/2012	Common Stock	44	$17.77	D
Option (right to buy)⁽¹⁾	⁽²⁾	07/20/2012	Common Stock	314	$17.77	D
Option (right to buy)⁽¹⁾	⁽²⁾	11/18/2012	Common Stock	802	$17.77	D
Option (right to buy)⁽¹⁾	⁽²⁾	08/15/2013	Common Stock	991	$17.77	D
Option (right to buy)⁽¹⁾	⁽²⁾	08/15/2014	Common Stock	758	$17.77	D
Option (right to buy)⁽¹⁾	⁽³⁾	09/02/2012	Common Stock	6,940	$33.46	D
Option (right to buy)⁽¹⁾	⁽³⁾	08/23/2014	Common Stock	8,288	$25.09	D
Option (right to buy)⁽¹⁾	⁽³⁾	10/17/2013	Common Stock	9,057	$33.26	D
Option (right to buy)⁽¹⁾	⁽⁴⁾	08/15/2015	Common Stock	11,014	$31.9	D
Restricted Stock Units⁽¹⁾⁽⁵⁾	⁽⁶⁾	⁽⁶⁾	Common Stock	2,733	⁽⁷⁾	D
Option (right to buy)	⁽⁸⁾	09/15/2016	Common Stock	41,517	$20.71	D
Restricted Stock Units⁽⁵⁾	⁽⁹⁾	⁽⁹⁾	Common Stock	23,803	⁽⁷⁾	D
Option (right to buy)	⁽¹⁰⁾	08/16/2017	Common Stock	32,965	$22.59	D
Restricted Stock Units⁽⁵⁾	⁽¹¹⁾	⁽¹¹⁾	Common Stock	10,229	⁽⁷⁾	D

Explanation of Responses:

1. Equity awards originally granted by Cardinal Health, Inc. ("Cardinal Health"). Pursuant to the anti-dilution provisions of each award, the number and kind of shares subject to it (and for options, the exercise price) were adjusted in conjunction with the spinoff of CareFusion Corporation from Cardinal Health on August 31, 2009.

2. Stock options granted in connection with the voluntary stock option exchange program conducted by Cardinal Health, with respect to stock options previously awarded by Cardinal Health. Pursuant to the stock option exchange program and the original terms of these stock options, these stock options are now fully exercisable.

3. Stock options granted subject to multi-year vesting based on original grant date. These stock options are now fully exercisable.

4. Stock options granted subject to multi-year vesting based on original grant date. These stock options are exercisable with respect to 7,341 shares and will vest as to 3,673 shares on August 15, 2011.

5. Each restricted stock unit represents a contingent right to receive one share of CareFusion common stock upon vesting.

6. Restricted stock units granted subject to multi-year vesting based on original grant date. The shares reflected above represent the unvested portion of the award, which will vest as to 2,733 shares on August 15, 2011.

7. Granted without payment by grantee.

8. Stock options granted on September 15, 2009. These stock options are exercisable with respect to 13,839 shares and will vest as to 13,839 shares on each of September 15, 2011 and September 15, 2012.

9. Restricted stock units granted on September 15, 2009. The shares reflected above represent the unvested portion of the award, which will vest as to 11,901 shares on September 15, 2011 and 11,902 shares on September 15, 2012.

10. Stock options granted on August 16, 2010. These stock options will vest as to 10,988 shares on August 16, 2011, 10,988 shares on August 16, 2012, and 10,989 shares on August 16, 2013.

11. Restricted stock units granted on August 16, 2010. These restricted stock units will vest as to 3,409 shares on August 16, 2011, 3,410 shares on August 16, 2012, and 3,410 shares on August 16, 2013

Remarks:

	Nathaniel Sisitsky, as Attorney-in-Fact for Gordon La Fortune	11/12/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.